Chiron Real Estate Inc. Stock: price and insider trades · United States · SEC (Form 4)

About Chiron Real Estate Inc.

Chiron Real Estate Inc. (NYSE: XRN) is a U.S.-listed healthcare real estate investment trust (REIT) focused on investing in the future of healthcare. The company frames its strategy around the intersection of care, capital, and real estate, with a portfolio designed to capture long-term demand driven by aging demographics and the need for healthcare-related property infrastructure. Chiron’s operating base is in Bethesda, Maryland, and the company is organized as a Maryland corporation. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1533615/000110465926056346/tm2613785d1_ex99-2.htm)) The most important recent corporate development is the company’s rebranding: Chiron Real Estate Inc. and the XRN ticker became effective on February 23, 2026, signaling a broader strategic repositioning. Management has described this as a reset of mission and values, with an emphasis on delivering value through more targeted healthcare real estate investments and better capital allocation. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1533615/000110465926019760/tm267304d1_ex99-2.htm?utm_source=openai)) Operationally, Chiron owns and manages a diversified healthcare property platform. Based on first-quarter 2026 supplemental reporting, the portfolio included about 5.1 million square feet across 189 properties, with annualized cash NOI of roughly $115.3 million and gross assets of about $1.5 billion. The portfolio lease occupancy stood at 95.4% at quarter-end, suggesting a relatively stable rent base. Chiron’s assets span single-tenant outpatient properties, multi-tenant outpatient properties, inpatient rehabilitation facilities, and other healthcare-related real estate. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1533615/000110465926056346/tm2613785d1_ex99-2.htm)) Chiron’s business model combines steady asset-level income with active portfolio management. In 2025, the company completed five acquisitions and seven dispositions, reflecting an ongoing effort to recycle capital and sharpen portfolio quality. It also invested in a Minneapolis-area active adult residential development joint venture, and in May 2026 it announced a strategic preferred equity investment of up to $100 million led by Maewyn Capital Partners. That transaction was presented as a key step in the company’s repositioning toward higher-return opportunities, including senior housing and other targeted healthcare sectors. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1533615/000110465926021956/xrn-20251231x10k.htm?utm_source=openai)) From an investment perspective, Chiron appears positioned as a healthcare real estate platform with a defensive income profile but meaningful transformation optionality. The NYSE listing gives it access to U.S. public markets, while the company’s healthcare focus and recent capital-structure actions could support future growth if execution remains disciplined. At the same time, the recent repositioning means investors should watch portfolio reallocation, funding costs, occupancy trends, and the pace at which management converts strategic capital into durable earnings growth. The sources reviewed do not highlight a long operating history or a widely promoted founding date, so the current investment case is best understood through the company’s recent strategic actions rather than through legacy scale alone. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1533615/000110465926056346/tm2613785d1_ex99-2.htm))